Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 801 - 850 out of 10,878

Document Document Title
WO2005080309A8
There is provided a stereoselective route to a compound of formula (1): wherein R represents H or an alkali metal, Ar<1> represents 4-chlorophenyl and Ar<2> represents 2,5-difluorophenyl.  
WO/2005/103035A1
The present invention relates to a new process for the preparation of eletriptan (I), or its enantiomer comprising a modified Fischer indole synthesis, namely the reaction of a compound of formula (II), wherein R1 is a suitable hydrazine...  
WO/2005/102989A1
The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula (I) where Ar, R1-R5, R11c and X1 are as defined herein.  
WO/2005/100309A1
The present invention provides compounds of the structure (I) wherein the constituent members are defined herein, including pharmaceutical compositions thereof and methods of treating diseases such as for example excessive sleepiness, pr...  
WO/2005/100298A1
Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the com...  
WO/2005/100311A1
The present invention provides compounds of formula (I), wherein the constituent members are defined in the claims, pharmaceutical compositions thereof and methods for treating excessive sleepiness associated with narcolepsy, obstructive...  
WO/2005/100292A1
The invention relates to novel photoinitators of formulae (I), (II), (III), (IV), (V) and (VI) wherein R1 and R2 are each independently of the other C1-C8alkyl; C1-C4alkyl substituted by OH, C1-C4alkoxy, -COO(C1-C8alkyl), (C1-C4alkyl)-CO...  
WO/2005/100345A1
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein Ar, Y, R1 and ...  
WO/2005/100310A1
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein Ar, X, Y, R1, ...  
WO/2005/100308A1
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl ace...  
WO/2005/097739A2
(Benzenesulfonyl)difluoromethyl anion, in situ generated from difluoromethyl phenyl sulfone and a base, was found to easily undergo nucleophilic substitution reactions (SN2 with primary alkyl halides, elemental halogens, and perfluoroalk...  
WO/2005/097738A1
Disclosed are a compound represented by the formula (1) below, a prodrug thereof, and their pharmaceutically acceptable salts which have an effect of increasing LDL receptor expression and are useful as drugs for treating hyperlipemia, a...  
WO/2005/095307A1
The invention relates to a method for forming a carbon-carbon bond between to aromatic cycles, thereby resulting in an aromatic compound. Said invention also relates to producing a carbon-carbon bond between an aromatic cycle and an unsa...  
WO/2005/095327A1
Novel compounds having kininogenase-inhibitory activity and medicinal uses thereof, specifically, compounds represented by the general formulae (A), (B), (C), (E) and (H) or medicinally acceptable salts thereof: (A) (C) (B) (E) (H) where...  
WO/2005/095335A1
The invention aims at providing ylide compounds represented by the general formula (1) and being useful as herbicide and a process for the production thereof, as well as at providing a process for the preparation of halomethyl ketones kn...  
WO/2005/092937A1
Disclosed is a fluorine-containing polymer having: (A) a repeating unit derived from a fluorine-containing monomer which is represented by the following formula: CH2=C(-X)-C(=O)-Y-[-(CH2)m-Z-]p-(CH2)n-Rf (I); (B) a repeating unit derived...  
WO/2005/092836A1
A compound of the formula (I) wherein the variables X1, X2, B, D, R1 to R7.including R3', p, y, q, and z, are as defined or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for t...  
WO/2005/092840A1
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invent...  
WO2005046599A3
alphabeta-Unsaturated sulfoxides of Formula I: (I) are useful as antiproliferative agents including, for example, anticancer agents, and as radioprotective and chemoprotective agents.  
WO/2005/092846A1
A method for reducing the cyanide levels in a mesotrione sample, said method comprising: (i) taking an aqueous solution of the mesotrione sample in an aqueous solvent, (ii) adjusting the pH of said aqueous solution to a value of 9.5 or h...  
WO/2005/092904A1
Novel styrylacrylonitrile compounds which are useful in treating a variety of cell proliferative disorders such as cancer are disclosed.  
WO/2005/092997A1
Disclosed is a surface treating agent containing a fluorine-containing polymer having: (A) a repeating unit derived from a fluorine-containing compound which is represented by the following formula: CH2=C(-X)-C(=O)-Y-[-(CH2)m-Z-]p-(CH2)n...  
WO/2005/090297A1
The invention relates to sulphonamide derivatives of formula (I), where RC is optionally substituted 4-6-membered heterocyclic ring containing one or more N atoms, or RC is -NR1R2, RA is a group having the formula (A), (B) or (C) RB is h...  
WO/2005/090296A2
The invention provides N-substituted benzenesulfonamides for use in treating or preventing cognitive disorders, such as Alzheimer's Disease. Compounds of particular interest are defined by Formula (I), wherein R1, R2, R3, R4, and R3, are...  
WO/2005/090298A1
The invention relates to sulphonamide derivatives of formula (I), where RC is optionally substituted 4-6-membered heterocyclic ring containing one or more N atoms, or RC forms together with the phenyl ring to which it is attached a benzo...  
WO/2005/089269A2
Substituted phenol derivatives of Formula (I) are useful as antiproliferative agents including, for example, anticancer agents, and as radioprotective and chemoprotective agents.  
WO/2005/089511A2
Crystalline salts, polymorphs, solvates, and hydrates of bicalutamide, 5-fluorouracil, donepezil, anastrozole, nelfinavir, mirtazapine, lansoprazole, and tamsulosin, or derivatives thereof are provided by the subject invention. Methods o...  
WO/2005/087710A1
A compound represented by the formula (1) (wherein the symbols are the same as defined in the description), a salt thereof, and a prodrug thereof. They unexpectedly have excellent GPR40 receptor agonistic activity and are excellent in pr...  
WO/2005/087700A2
The present invention discloses bisphenyl compounds of the formula (1): wherein R1, R2, R3, R4, R5, R6, X, Y, W are defined herein after. These compounds are useful as pharmaceuticals.  
WO/2005/085190A1
The invention relates to a method for processing ß-sulphatoethylsulphonylaniline-2-sulphonic acid which is present as a solution in an aqueous sulphuric acid. In a first step, the ß-sulphatoethylsulphonylaniline-2-sulphonic acid is pre...  
WO/2005/080309A1
There is provided a stereoselective route to a compound of formula (1): wherein R represents H or an alkali metal, Ar1 represents 4-chlorophenyl and Ar2 represents 2,5-difluorophenyl.  
WO2005063665B1
The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to i...  
WO2005051899A3
A novel polymer electrolyte is provided that enables a solid polymer electrolyte used in fuel cells, for example, to have sufficient proton conductivity even in a low-water-content state or a zero-water-content state by using a monomer c...  
WO/2005/079700A2
The present invention relates to methods of using fluorosulfones for i) extinguishing fire by applying to the fire such a fluorosulfone, ii) preventing fire in an air-containing enclosed area containing combustible materials by introduci...  
WO/2005/079270A2
The present invention provides aryl nitrones, compositions comprising the same and methods of their use for the treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine mediated conditions.  
WO/2005/079863A1
It is intended to provide a contrast medium for thrombus formation capable of binding specifically to a thrombus, lowering background noise and thus improving the resolution in a contrast examination for thrombus formation; and a method ...  
WO/2005/078741A1
Disclosed are a mixture and a cation conductor which are capable of transferring cations without humidification even in the temperature range not higher than the boiling point of water. Also disclosed is an electrochemical device such as...  
WO/2005/077894A1
Polymorphs and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil are formed and discussed. In addition, said forms are described as useful for the treatment of many conditions including, but not limited to,...  
WO/2005/077122A2
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).  
WO/2005/075426A1
The present invention relates to novel dipeptidyl peptidase IV (DPP-IV) inhibitors or general formula (1) useful for treating diabetes, non-insulin dependent diabetes mellitus, impaired glucose tolerance, inflammatory bowel disease, ulce...  
WO/2005/075417A1
The present invention relates to new fluorosulfone compounds. These fluorosulfone compounds have utility in preventing, controlling and extinguishing fire.  
WO2005056510A3
The present invention relates to novel compounds corresponding to the general formula (I) below: to compounds containing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, or alternati...  
WO/2005/073165A1
The invention aims at providing highly effective insecticides. Compounds represented by the general formula (1); insecticides containing the same as the active ingredient; and a process for the production thereof: (1) wherein A1, A2, A3 ...  
WO2005051898A3
The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1alpha,25 dihydroxy vitamin D3. These com...  
WO2004014847A8
The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists.  
WO2005051888A3
The invention relates to compounds of the formula (I) in which: i and j=1; R1 is in position 3 or 4 on the phenyl ring and represents a cyano group, an alkoxy group substituted by halogen, a thioalkyl group, an alkylcarbonyl group or an ...  
WO2005037206A3
The present invention relates to a novel class of anti-cancer compounds which selectively target androgen receptor (AR)-expressing cancer, cells, such as prostate cancer cells and breast cancer cells, These agents comprise an androgen re...  
WO/2005/070883A1
The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H)-furanones useful in the treatment of cyclooxygenase-2 mediated diseases. Formula (I). The invention also encompasses certa...  
WO/2005/070874A1
The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H) furanones useful in the treatment of cyclooxygenase-2 mediated diseases. Formula (I). The invention also encompasses certa...  
WO/2005/068411A1
A process for the preparation of 6-fluoro-2-methyl-l-indanone which relates to a process of preferential cyclization of (3-fluorophenyl)-isopropenyl-ketone to obtain 6-fluoro-2-methyl­ 1-indanone regioisomer with respect to 4-fluoro-2-m...  

Matches 801 - 850 out of 10,878